Evolus, Inc.
Industry: Life Sciences ・ $EOLS on Nasdaq
Insider Sale
+$113,947
-1.97%
Shares
Shares Volume: 10,502 Shares
Average Share Price: $10.85
INSIDER
MOATAZEDI DAVID
See Remarks (Director)
reported on Dec 26 2024
traded on Dec 23 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 522,847 |
| PURCHASES/SALES 1Y | 0 / 6 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $1,310,049.6 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 0 / 18 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $518,401.25 |
| COMPANY PREVIOUS TRADES |